Bruyère, Olivier http://orcid.org/0000-0003-4269-9393
Reginster, Jean-Yves
Honvo, Germain
Detilleux, Johann
Funding for this research was provided by:
MEDA
Article History
Received: 26 November 2018
Accepted: 18 January 2019
First Online: 12 February 2019
Compliance with ethical standards
:
: This study was supported by an unrestricted educational grant from MEDA. MEDA is the Marketing Authorisation Holder of crystalline glucosamine sulfate. The design, conduct and analysis of the study were under the sole responsibility of the Department of Public Health, Epidemiology and Health Economics of the University of Liège, without any intervention from third parties, including MEDA. Similarly, the preparation, writing, review and submission of the paper were under the sole responsibility of the authors. O. Bruyere reports grants from Biophytis, IBSA, MEDA, Servier, SMB, and Theramex. J-Y. Reginster reports grants from IBSA-Genevrier, Mylan, CNIEL, Radius Health, consulting fees from IBSA-Genevrier, Mylan, CNIEL, Radius Health, Pierre Fabre, fees for participation in review activities from IBSA-Genevrier, MYLAN, CNIEL, Radius Health, Teva, payment for lectures from AgNovos, CERIN, CNIEL, Dairy Research Council (DRC), Echolight, IBSA-Genevrier, Mylan, Pfizer Consumer Health, Teva, Theramex. Other have no potential conflicts of interest.
: Not applicable.
: Not applicable.